2021 annual financial data
Atrium Therapeutics 2021 Net margin
Direct answer
Net margin was -1,258.52%.
Operating income was -118,051,000 USD and net income was -117,370,000 USD.
Operating cash flow was -94,813,000 USD.
Get free Atrium Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,326,000 USD
- Operating income
- -118,051,000 USD
- Net income
- -117,370,000 USD
- Operating cash flow
- -94,813,000 USD